Literature DB >> 20094929

Data safety monitoring boards: legal and ethical considerations for research accountability.

Patricia M Tereskerz1.   

Abstract

Those charged with assuring research accountability have little guidance as to how to best structure and manage data safety monitoring boards (DSMBs). One major concern is increased litigation surrounding human subject research which has led research institutions and those asked to serve on DSMBs to seek legal counsel regarding their risk of liability for DSMB activities. A major challenge is assessing the risk of potential liability. Yet, potential liability for DSMBs and their members has not been adequately addressed in the literature. The purpose of this article is to provide a legal and accountability analysis to begin to fill this gap. This article undertakes an analysis and exploration of the potential liability that exists for DSMBs and their members under negligence theory and discusses the means by which DSMBs and their members may avoid litigation or defend themselves in the face of a lawsuit. Research accountability implications of imposing liability, or not, on DSMBs are also considered. It is suggested that legislation be contemplated requiring sponsors to indemnify DSMBs and their members in the face of litigation.

Entities:  

Mesh:

Year:  2010        PMID: 20094929     DOI: 10.1080/08989620903520313

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  6 in total

1.  Data Monitoring Committees: Current issues.

Authors:  Thomas R Fleming; Susan S Ellenberg; David L DeMets
Journal:  Clin Trials       Date:  2018-04-09       Impact factor: 2.486

2.  Enhancing trial integrity by protecting the independence of data monitoring committees in clinical trials.

Authors:  Thomas R Fleming; Charles H Hennekens; Marc A Pfeffer; David L DeMets
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

3.  Data monitoring committees: Promoting best practices to address emerging challenges.

Authors:  Thomas R Fleming; David L DeMets; Matthew T Roe; Janet Wittes; Karim A Calis; Amit N Vora; Alan Meisel; Raymond P Bain; Marvin A Konstam; Michael J Pencina; David J Gordon; Kenneth W Mahaffey; Charles H Hennekens; James D Neaton; Gail D Pearson; Tomas Lg Andersson; Marc A Pfeffer; Susan S Ellenberg
Journal:  Clin Trials       Date:  2017-02-01       Impact factor: 2.486

4.  Creation of an institutional semi-independent data monitoring committee.

Authors:  Lisa R Tannock; Marietta Barton-Baxter; William W Stoops
Journal:  Clin Trials       Date:  2019-07-01       Impact factor: 2.486

5.  Maternal Perceptions of Safeguards for Research Involving Children.

Authors:  Maryam Rostami; Jane Paik Kim; Laura Turner-Essel; Laura Weiss Roberts
Journal:  J Child Fam Stud       Date:  2021-08-07

Review 6.  Protecting clinical trial participants and protecting data integrity: are we meeting the challenges?

Authors:  Susan S Ellenberg
Journal:  PLoS Med       Date:  2012-06-12       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.